Have a personal or library account? Click to login
Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients? Cover

Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients?

Romanian Journal of Internal Medicine
Volume 62 (2024): Issue 1 (March 2024)
By: Mohammad S. Alkader,  Rashed Z. Altaha,  Eslam H. Jabali,  Ola A. Attieh and  Ala’ W. Matalqa  
Open Access
|Mar 2024
DOI: https://doi.org/10.2478/rjim-2023-0025 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 33 - 43
Submitted on: Jul 22, 2023
Published on: Mar 23, 2024
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Hyperprogressive Disease,
Immunotherapy,
Lymph Nodes,
Renal Cell Carcinoma,
Risk Factors
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2024 Mohammad S. Alkader, Rashed Z. Altaha, Eslam H. Jabali, Ola A. Attieh, Ala’ W. Matalqa, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 62 (2024): Issue 1 (March 2024)Next article